以第一作者或共同第一作者发表中英文论文13篇👩‍👧‍👧，其中第一作者的SCI论文8篇👩🏽‍🎤，包括JTO, Cancer, Lung Cancer等肺癌研究主要杂志,总SCI达40余分；参编/编译《肺癌生物靶向治疗》和《新编肺癌综合治疗》；目前已经申请获得主持上海市科委的项目2项,研究的主要方向是：血液循环肿瘤细胞在肺部良恶性疾病及诊疗中的作用。相关的研究多次在国内外大会如🤛🏿🪸：CSCO，ASCO及全国肺癌大会上进行壁报及口头报告。2014年作为参与者获得2014年华夏医学科技一等奖👈🏽。

She had published 13 articles both in Chinese and English as first author, including 8 SCI articles. The articles published in JTO, Cancer, Lung Cancer were accounted to more than 40 points. She edited and complied 2 books( Biological target treatment of lung cancer and Comprehensive treatment of lung cancer).Now she got 2 programs from the Shanghai Municipal Science and Technology Commission. The main research direction is :The role of circulation tumor cells in peripheral blood in benign and malignant pulmonary diseases,diagnosis and treatment. The related research results were posted or oral in World congress such as CSCO,ASCO and the national lung cancer conference. As a main participant, she was got 1st prize in Chinese medical science and technology in 2014.